MA (EU) number 
(Invented) name 
Strength  Pharmaceutical Form 
EU/1/11/745/001 
EU/1/11/745/002 
EU/1/11/745/003 
EU/1/11/745/004 
EU/1/11/745/005 
EU/1/11/745/006 
EU/1/11/745/007 
EU/1/11/745/008 
EU/1/11/745/009 
EU/1/11/745/010 
EU/1/11/745/011 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
Desloratadine Actavis 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
5 mg 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Route of 
Administration 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Immediate Packaging 
Pack size 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
blister (OPA/alu/PVC/alu) 
bottle (HDPE) 
bottle (HDPE) 
7 tablets 
10 tablets 
14 tablets 
20 tablets 
21 tablets 
30 tablets 
50 tablets 
90 tablets 
100 tablets 
30 tablets 
100 tablets 
1/1 
 
 
 
